Speaker illustration

Doctor Johannes Schmucker

Hospital Links der Weser, Bremen (Germany)

Member of:

European Society of Cardiology

Impact of very high doses of contrast media on acute kidney injury rates in patients admitted with ST-elevation myocardial infarctions

Event: ESC Congress 2023

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Treatment of acute coronary syndromes in clinical practice

Thumbnail

Temporal trends in severe obesity for patients with ST-elevation myocardial infarctions in patient cohorts stratified by age and gender

Event: ESC Congress 2023

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Real-world evidence in acute coronary syndromes (2)

Thumbnail

Temporal trends in adverse ischemic events, bleedings, kidney injury and overall mortality for patients with ST-elevation myocardial infarctions and advanced kidney disease

Event: ESC Congress 2021 - The Digital Experience

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Acute Coronary Syndromes ePosters

Thumbnail

Association of bleeding events and acute kidney failure in patients with ST-Elevation myocardial infarcation undergoing emergency percutaenous coronary intervention

Event: ESC Congress 2021 - The Digital Experience

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Acute Coronary Syndromes ePosters

Thumbnail

Development of 1- and 5-year outcomes between 2006 and 2018 in patients with uncomplicated ST-elevation myocardial infarctions and successful percutaneous coronary intervention

Event: ESC Congress 2020

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Acute Coronary Syndromes ePosters

Thumbnail

Definition of clinically relevant thresholds of acute kidney injury in patients with ST-elevation myocardial infarctions undergoing primary percutaneous coronary interventions

Event: ESC Congress 2019

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Acute coronary syndrome risk, other

Thumbnail

Benefit of modern P2Y12-inhibitors on long-term prognosis in patients with ST-elevation myocardial infarction with and without advanced chronic kidney disease

Event: ESC Congress 2019

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Translational research in acute coronary syndrome registries

Thumbnail

Clinical benefit of prasugrel versus clopidogrel in patients with ST-elevation myocardial infarction treated with primary coronary intervention in patient-cohorts prestratified by overall risk

Event: ESC Congress 2018

Topic: Treatment

Session: Pharmacologic treatment of acute coronary syndromes

Thumbnail

Trends in mortality and MACCE-rates between 2006 and 2016 in patients with ST-elevation myocardial infarctions and a low overall risk

Event: ESC Congress 2018

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Prediction of acute coronary syndromes prognosis

Thumbnail

Efficacy and safety of ticagrelor in comparison to clopidogrel in elderly patients with ST-segment elevation myocardial infarctions

Event: ESC Congress 2017

Topic: Infarction acute phase STEMI

Session: Acute coronary syndromes: the full picture

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb